Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry

INTRODUCTION: Inflammatory bowel disease (IBD) frequently requires chronic immunosuppressive treatment and active involvement from patients during treatment decision making. Information about the risk of developing adverse drug reactions (ADRs) to IBD therapies is required in this process. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales: Giraud, Eline L., Thomas, Pepijn W. A., van Lint, Jette A., van Puijenbroek, Eugene P., Römkens, Tessa E. H., West, Rachel L., Russel, Maurice G. V. M., Jansen, Jeroen M., Jessurun, Naomi T., Hoentjen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053178/
https://www.ncbi.nlm.nih.gov/pubmed/33538994
http://dx.doi.org/10.1007/s40264-021-01045-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053178/
https://www.ncbi.nlm.nih.gov/pubmed/33538994
http://dx.doi.org/10.1007/s40264-021-01045-3

Ejemplares similares